[Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders]

[Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders] Abstract Text:

H Heidrich,

On the basis of pharmacological and clinical studies this review describes the effects of prostaglandin E1 (PGE1) on the cardiopulmonary system and its profile of adverse reactions taking into account spontaneous reports of side effects. All in all no increased risk of cardiovascular adverse reactions was obvious. PGE1 rather showed some desirable effects on heart and lung. Thus the analysis revealed a positive risk benefit relation for PGE1, provided that dosage and contra-indications are not neglected.

[Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders] Publishing Authors By Initials

H Heidrich,

For similar investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research abstracts see: investigative techniques: epidemiologic methods: statistics as topic: probability: risk: risk factors research

PUBMED ID PMID:

MEDLINE DATE:

[Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: VASA. Supplementum

VOLUME: 33

Page Numbers: 346-7

Journal Abbreviation:

ISSN: 0251-1029

DAY: 21

MONTH: 02

YEAR: 1991

[Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 8704474

[Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders] Keywords Mesh Terms:

KEYWORDS: Risk Factors

MESH TERMS: drug effects

Chemical & Substance for Abstract: [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders] Information

Substance Name: Alprostadil

Registry Number: 745-65-3

Grant and Affiliation Information for [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders]

AFFILIATION: Franziskus-Krankenhaus Berlin.

Country: SWITZERLAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Vasa Suppl

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders Related Publications

• Delirium: an under-recognized problem.
• Frequency of non-vascular accompanying diseases in patients with peripheral arterial disease.
• Incidence of thrombophlebitis with naftidrofuryl.
• Intimate partner violence among pregnant thai women.
• Long-term follow-up of thromboangiitis obliterans.
• Longterm pH-measurements in the hind limb of the dog.
• Not Available
• Patterns of pain and well-being in older women: a 10-year longitudinal study.
• Three-dimensional, non-destructive visualization of vertical root fractures using flat panel volume detector computer tomography: an ex vivo in vitro case report.
• Vital capillary microscopic findings in the nailfold of patients with diabetes mellitus.
• Vital capillary-microscopic findings in normal subjects, patients with peripheral arterial occlusive disease (Fontaine II to IV) and patients with thrombangiitis obliterans.
• [Acute cerebro-vascular insufficiency]
• [Capillary microscopy findings in chronic polyarthritis and endangiitis obliterans]
• [Cerebellar migraine.]
• [Color-coded duplex sonography of lower leg arteries--imaging for classification of Fontaine stages]
• [Combined transcutaneous measurement of partial O2 and CO2 pressure as a diagnostic supplement in assessing the degree of severity of peripheral arterial occlusive disease]
• [Contact plate thermography with cold provocation tests for the diagnosis of Raynaud's phenomenon]
• [Defibrination with ancrod (arvin) in peripheral arterial occlusive diseases. Principle, indications, contraindications technic and course]
• [Definition and terminology of Raynaud's syndrome.]
• [EEG studies after electro-trauma.]
• [Edema disease in the pig]
• [Effect of isoxsuprine on blood viscosity]
• [Laser Doppler flowmetry in probands with healthy vessels and in patients with Fontaine stage II-IV peripheral arterial occlusive disease]
• [Not Available.]
• [Not Available.]
• [Peripheral arterial occlusions. Principles, possibilities and limits of conservative therapy]
• [Risk-benefit analysis of intra-arterial and intravenous PGE1 infusions in peripheral arterial occlusive disorders]
• [Studies of the correlation of vital capillary microscopy findings and transcutaneous oxygen partial pressure in patients with peripheral arterial occlusive disease (Fontaine stage II-IV)]